Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Terminated
2(29%)

Phase Distribution

Ph phase_4
1
14%
Ph phase_2
1
14%
Ph not_applicable
2
29%
Ph phase_3
3
43%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
3(42.9%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(4)
Terminated(3)

Detailed Status

Completed4
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (14.3%)
Phase 33 (42.9%)
Phase 41 (14.3%)
N/A2 (28.6%)

Trials by Status

withdrawn114%
terminated229%
completed457%

Recent Activity

0 active trials
Showing 5 of 7
completednot_applicable

Interval Intraocular Pressure in Intravitreal Injection Study

NCT04868175
completedphase_2

Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost

NCT00637130
terminatedphase_3

Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT

NCT00767494
terminatedphase_4

Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension

NCT00471068
withdrawnphase_3

Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%

NCT01452009
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT04868175Not Applicable

Interval Intraocular Pressure in Intravitreal Injection Study

Completed
NCT00637130Phase 2

Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost

Completed
NCT00767494Phase 3

Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT

Terminated
NCT00471068Phase 4

Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension

Terminated
NCT01452009Phase 3

Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%

Withdrawn
NCT00051168Phase 3

A Long-term Safety Study of Once-daily Travatan

Completed
NCT00121147Not Applicable

Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7